Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2008 Apr 1;117(13):1675-84.
doi: 10.1161/CIRCULATIONAHA.107.730614. Epub 2008 Mar 24.

Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease

Heribert Schunkert  1 , Anika Götz, Peter Braund, Ralph McGinnis, David-Alexandre Tregouet, Massimo Mangino, Patrick Linsel-Nitschke, Francois Cambien, Christian Hengstenberg, Klaus Stark, Stefan Blankenberg, Laurence Tiret, Pierre Ducimetiere, Andrew Keniry, Mohammed J R Ghori, Stefan Schreiber, Nour Eddine El Mokhtari, Alistair S Hall, Richard J Dixon, Alison H Goodall, Henrike Liptau, Helen Pollard, Daniel F Schwarz, Ludwig A Hothorn, H-Erich Wichmann, Inke R König, Marcus Fischer, Christa Meisinger, Willem Ouwehand, Panos Deloukas, John R Thompson, Jeanette Erdmann, Andreas Ziegler, Nilesh J Samani; Cardiogenics Consortium
Collaborators, Affiliations
Meta-Analysis

Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease

Heribert Schunkert et al. Circulation. .

Abstract

Background: Recently, genome-wide association studies identified variants on chromosome 9p21.3 as affecting the risk of coronary artery disease (CAD). We investigated the association of this locus with CAD in 7 case-control studies and undertook a meta-analysis.

Methods and results: A single-nucleotide polymorphism (SNP), rs1333049, representing the 9p21.3 locus, was genotyped in 7 case-control studies involving a total of 4645 patients with myocardial infarction or CAD and 5177 controls. The mode of inheritance was determined. In addition, in 5 of the 7 studies, we genotyped 3 additional SNPs to assess a risk-associated haplotype (ACAC). Finally, a meta-analysis of the present data and previously published samples was conducted. A limited fine mapping of the locus was performed. The risk allele (C) of the lead SNP, rs1333049, was uniformly associated with CAD in each study (P<0.05). In a pooled analysis, the odds ratio per copy of the risk allele was 1.29 (95% confidence interval, 1.22 to 1.37; P=0.0001). Haplotype analysis further suggested that this effect was not homogeneous across the haplotypic background (test for interaction, P=0.0079). An autosomal-additive mode of inheritance best explained the underlying association. The meta-analysis of the rs1333049 SNP in 12,004 cases and 28,949 controls increased the overall level of evidence for association with CAD to P=6.04x10(-10) (odds ratio, 1.24; 95% confidence interval, 1.20 to 1.29). Genotyping of 31 additional SNPs in the region identified several with a highly significant association with CAD, but none had predictive information beyond that of the rs1333049 SNP.

Conclusions: This broad replication provides unprecedented evidence for association between genetic variants at chromosome 9p21.3 and risk of CAD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HapMap data (r2) of all SNPs of the chromosome 9 region (listed in online-only Data Supplement Table I) of Samani et al and the lead SNPs of McPherson et al and Helgadottir et al. The lead SNPs of former studies and the present study are marked.
Figure 2
Figure 2
Haplotypic ORs and 95% CIs associated with the ACAC haplotypes under the assumption of additive haplotype effects. Boxes indicate the relative sizes of the samples.
Figure 3
Figure 3
Heterozygous and homozygous ORs and 95% CIs under the assumption of an additive model. Boxes indicate the relative sizes of the samples. Effects were estimated from frequency tables presented on replication samples of the previously published studies (GerMIFS I: rs1333049; OHS-2, ARIC, CCHS, DHS, OHS-3: rs2383206; Iceland B, Atlanta, Philadelphia, Durham: rs107572786).
See this image and copyright information in PMC

References

    1. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041–1046. - PubMed
    1. Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA. 2007;297:1551–1561. - PubMed
    1. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Metinger T, Braund P, Wichmann H-E, Barrett J, König IR, Stevens S, Szymczak S, Tregouet D-A, Iles MM, Pahlke F, Pollard H, Lieb M, Cambien F, Fischer M, Ouwehamd W, Blankenberg S, Balmforth A, Baessler A, Ball S, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin M, Ziegler A, Thompson J, Schunkert H, the WTCCC and Cardiogenics Consortium Genomewide Association Analysis of Coronary Artery Disease Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:497–499. - PMC - PubMed
    1. Welcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–678. - PMC - PubMed
    1. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E, Hobbs HH, Cohen JC. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–1491. - PMC - PubMed

Publication types

Substances